Detection of acute myocardial infarct with T1-mapping post ferumoxytol contrast administration

Detection of acute myocardial infarct with T1-mapping post ferumoxytol contrast administration

Bibliographic Details
Main Authors:	Spatz Deneen, Klem Igor, Van Assche Lowie M, Chen Enn-Ling, Rehwald Wolfgang G, Kim Han W, Jensen Christoph J, Wendell David, Jenista Elizabeth, Kim Raymond J
Format:	Article
Language:	English
Published:	BMC 2013-01-01
Series:	Journal of Cardiovascular Magnetic Resonance

Similar Items

Time course of the effect of ferumoxytol on T1-relaxation times of blood, liver, myocardium, and acute infarction
by: Spatz Deneen, et al.
Published: (2012-02-01)

The relationship of the transmural extent of T2-edema compared with the transmural extent of infarction: implications for the assessment of the area-at-risk
by: Spatz Deneen M, et al.
Published: (2011-02-01)

Highly effective fat suppression in clinical T1-weighted imaging of ischemic and non-ischemic heart disease with DeSPAIR
by: Rehwald Wolfgang G, et al.
Published: (2012-02-01)

Design of an adiabatic T2-preparation method optimized for cardiac motion and flow insensitivity at 3T
by: Chen Enn Ling, et al.
Published: (2011-02-01)

Phase sensitive inversion recovery with simultaneous dark fat rendering by virtual chemical inversion
by: Jenista Elizabeth, et al.
Published: (2012-02-01)

The ferumoxytol in renal insufficiency study (FiRST)
by: Vemulapalli Sreekanth, et al.
Published: (2013-01-01)

Assessment and improvement of image homogeneity in black-blood T2-weighted turbo spin-echo CMR
by: Wince Benjamin, et al.
Published: (2012-02-01)

Myocardial salvage by T2W-CMR: direct comparison to a non-destructive, high resolution, 3-dimensional ex-vivo assessment of the area at risk simultaneous with infarction
by: Van Assche Lowie M, et al.
Published: (2013-01-01)

Implementing total-dose ferumoxytol in lieu of split-dose ferumoxytol
by: Au, L., et al.
Published: (2021)

Quantifying the area at risk using the infarct lateral border: importance of infarct transmurality
by: Jensen Christoph J, et al.
Published: (2012-02-01)

A novel index of infarct morphology predicts the presence of microvascular obstruction in patients with acute myocardial infarction
by: Van Assche Lowie M, et al.
Published: (2012-02-01)

Evaluation of renal quantitative T2* changes on MRI following administration of ferumoxytol as a T2* contrast agent
by: Hedgire SS, et al.
Published: (2014-04-01)

Comparison of methods for DE-CMR infarct size quantification - reproducibility among three core labs
by: Klem Igor, et al.
Published: (2013-01-01)

Imaging Tumor Necrosis with Ferumoxytol.
by: Maryam Aghighi, et al.
Published: (2015-01-01)

Sources of variability in quantification of cardiovascular magnetic resonance infarct size - reproducibility among three core laboratories
by: Igor Klem, et al.
Published: (2017-08-01)

Ferumoxytol enhanced black-blood cardiovascular magnetic resonance imaging
by: Kim-Lien Nguyen, et al.
Published: (2017-12-01)

A new CMR protocol for non-destructive, high resolution, ex-vivo assessment of the area at risk simultaneous with infarction: validation with histopathology
by: Van Assche Lowie M, et al.
Published: (2012-02-01)

Adiabatic T2-preparation modules optimized for robustness toward cardiac motion and flow - a comparison with existing techniques at 3 Tesla
by: Chen Enn-Ling, et al.
Published: (2011-02-01)

Virtual chemical inversion - a novel fat suppression technique for T1-weighted cardiac imaging with improved delineation of the fat-myocardium interface
by: Jenista Elizabeth, et al.
Published: (2013-01-01)

A new method to suppress ghosting artifacts arising from long-T1 species in segmented inversion recovery (IR) sequences
by: Chen Enn-Ling, et al.
Published: (2011-02-01)

Application of continuous composite RF pulses as components of a fat-suppressed T2-preparation module for 3 Tesla - evaluation of its fat suppression efficiency in clinical cardiac patients
by: Kim Panki, et al.
Published: (2013-01-01)

The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale
by: Iain C. Macdougall, et al.
Published: (2017-04-01)

Correction to: The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale
by: Iain C. Macdougall, et al.
Published: (2018-04-01)

MYOCARDIAL CONTRAST ECHOCARDIOGRAPHY IN ACUTE ST ELEVATION MYOCARDIAL INFARCTION
by: Martin Tretjak
Published: (2004-07-01)

The Emerging Role of Ferumoxytol-Enhanced MRI in the Management of Cerebrovascular Lesions
by: David Hasan, et al.
Published: (2013-08-01)

Ferumoxytol for the treatment of iron deficiency and iron-deficiency anemia of pregnancy
by: Jesse Gerb, et al.
Published: (2021-05-01)

Myocardial contrast echocardiography – Use in viability assessment and acute myocardial infarction
by: Jiwan Pradhan, et al.
Published: (2019-01-01)

Ferumoxytol Attenuates the Function of MDSCs to Ameliorate LPS-Induced Immunosuppression in Sepsis
by: Yujun Xu, et al.
Published: (2019-12-01)

Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer
by: Vadhan-Raj S, et al.
Published: (2017-12-01)

Blood volume measurement using cardiovascular magnetic resonance and ferumoxytol: preclinical validation
by: Rajiv Ramasawmy, et al.
Published: (2018-09-01)

Materials Characterization of Feraheme/Ferumoxytol and Preliminary Evaluation of Its Potential for Magnetic Fluid Hyperthermia
by: Jon Dobson, et al.
Published: (2013-08-01)

High resolution, 3-dimensional Ferumoxytol-enhanced cardiovascular magnetic resonance venography in central venous occlusion
by: Puja Shahrouki, et al.
Published: (2019-03-01)

Ferumoxytol-enhanced cardiovascular magnetic resonance detection of early stage acute myocarditis
by: Yuko Tada, et al.
Published: (2019-12-01)

Safety and efficacy of a single total dose infusion (1020 mg) of ferumoxytol
by: Harris Khan, et al.
Published: (2021-04-01)

Characterization of acute myocardial infarction by pre-contrast T1 mapping
by: Dall'Armellina Erica, et al.
Published: (2012-02-01)

A simple visual algorithm incorporating the components of a routine CMR study improves the determination of infarct age compared with T2-CMR alone
by: Smulders Martijn W, et al.
Published: (2013-01-01)

Unrecognized non-Q-wave myocardial infarction: prevalence and prognostic significance in patients with suspected coronary disease.
by: Han W Kim, et al.
Published: (2009-04-01)

Evaluation of stunned and infarcted canine myocardium by real time myocardial contrast echocardiography
by: P.M.M. Dourado, et al.
Published: (2003-11-01)

A Comparison between Myocardial Contrast Echocardiography and Radionuclide Myocardial perfusion Imaging in Patients with Acute Myocardial Infarction
by: Dwivedi, Girish
Published: (2010)

Reproducibility of myocardial salvage in acute myocardial infarction by the use of Contrast-Enhanced Magnetic Resonance Imaging
by: Thiele Holger, et al.
Published: (2009-01-01)